Tianjin Tianyao Pharmaceuticals (600488.SH): Formoterol fumarate inhalation solution has obtained a drug registration certificate.
Tianjin Pharmaceutical (600488.SH) announced that its subsidiary, Tianjin He Ping Pharmaceutical Co., Ltd....
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary Jin Yao Heping (Tianjin) Pharmaceutical Co., Ltd. ("Jin Yao Heping") has received the Drug Registration Certificate for the approval and issuance of formoterol fumarate inhalation solution from the National Medical Products Administration.
It is reported that formoterol fumarate inhalation solution is suitable for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), primarily used for chronic bronchitis and emphysema, and can produce long-lasting anti-asthmatic effects. Up to now, Jin Yao Heping has accumulated research and development expenses of approximately 3.97 million yuan for the formoterol fumarate inhalation solution project.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
